German MedCanG Amendment Set to Take Effect in Q2 — Foreign Prescription Recognition Suspended; Price Controls Introduced
The amendment to Germany’s Medical Cannabis Act (MedCanG) is scheduled to take effect in the second quarter. By suspending recognition of foreign prescriptions and introducing price-control measures, the reform is expected to substantially reshape the structure of Germany’s medical cannabis market.
For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.
Source
businessofcannabis.com
This content is a summary and editorial by CannabisInsight based on the above source. Copyright of the original article belongs to the respective publisher.
Original Link
https://businessofcannabis.com/deals-courts-and-coalition-splits-germanys-cannabis-market-braces-for-change/